Did Hillary Clinton really faint from “dehydration” or does she have a chronic neurological condition?

Posted on February 24, 2018 by admin

September 12, 2016- by Steven E. Greer, MD

Once again, the Hillary Clinton campaign is on defense after another health scare from their Continue reading →

Posted in - Policy, Cardiology, Congress, Emergency medicine, Neurology, NYU, Ophthalmology, Primary care medicine, Radiology | Leave a comment

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer (FLAURA)

Posted on February 23, 2018 by admin

November 20, 2017- Interviewed by Steven E. Greer, MD

We interviewed Emory University oncologist Suresh S. Ramalingam, M.D. about his NEJM Continue reading →

Posted in - NEJM, Cardiac surgery, Emory, Oncology | Leave a comment

Oh my god, I have a disease!

Posted on February 21, 2018 by admin

March 21, 2014- This DTC TV drug ad medicalizing a non-disease really struck us as egregious

Posted in - Pharma, Congress, FDA | Leave a comment

US Senator calls for transparency in medical device pricing

Posted on February 14, 2018 by admin

Posted in - Medical Devices, Congress | Leave a comment

HBO’s John Oliver devotes 16-minutes on the Dr. Oz senate hearing

Posted on February 9, 2018 by admin

Posted in - Opinion, Cardiac surgery, Congress | Leave a comment

Football head injuries down after rules change

Posted on January 19, 2018 by admin

NFL-concussionUpdate January 20, 2015- The PBS news show Frontline has been tracking the number Continue reading →

Posted in - Opinion, - Policy, Neurosurgery, Primary care medicine, Psychology Psychiatry, Spine surgery, Sports medicine | Leave a comment

Increasing rates of double mastectomies in early stage breast cancer

Posted on January 15, 2018 by admin

November 22, 2013- Interviewed by Steven E. Greer, MD

David P. Winchester MD, Medical Director of Cancer Programs for the American College of Surgeons, Continue reading →

Posted in - Policy, Oncology, Plastic surgery | Leave a comment

The serious adverse events caused by antipsychotics

Posted on January 13, 2018 by admin

February 1, 2014 Continue reading →

Posted in - Pharma, FDA | Leave a comment

Steve Bannon and the epidemic of Baby Boomers with mental illness

Posted on January 5, 2018 by admin

January 5, 2017- by Steven E. Greer, MD

President Trump made news yesterday by issuing a statement firing back at Steve Bannon for allegations Continue reading →

Posted in - Opinion, - Pharma, - Policy, Geriatrics, Neurology, Psychology Psychiatry, Rehab | Leave a comment

CT-scan screening for heart disease fails to show benefit

Posted on January 5, 2018 by admin

March 23, 2015- Interviewed by Steven E. Greer, MD

We interviewed the Principal Investigator of the PROMISE trial, Pamela Douglas, MD from Duke. Continue reading →

Posted in - NEJM, - Policy, Cardiology, CMS, Duke, Radiology | Leave a comment

What Steve Jobs would have invented if he had lived longer

Posted on January 4, 2018 by admin

Steve-JobsUpdate January 29, 2014- Apple posted Q4 earnings so big that they are incomprehensible. Continue reading →

Posted in - Medical Devices, - Opinion | Leave a comment

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

Posted on January 4, 2018 by admin

May 23, 2017- interviewed by Steven E. Greer, MD

We interviewed polumonologist Michael Wechsler, MD about his paper in the NEJM testing mepolizumab Continue reading →

Posted in - NEJM, National Jewish Health, Pulmonology, Rheumatology | Leave a comment

The super shady methods of pricing generic drugs in America: case study- Sildenafil

Posted on January 4, 2018 by admin

Generic revatioMay 15, 2016- by Steven E. Greer, MD

The last I read, Teva and Mylan were not supposed to launch their approved generic of Viagra (sildenafil) Continue reading →

Posted in - Generics, - Opinion, - Pharma, CMS, Congress, FDA | Leave a comment

What 1982’s Blade Runner got right about 2019

Posted on January 4, 2018 by admin

September 3, 2017- by Steven E. Greer, MD

I watched again the 1982 classic Blade Runner. Directed by Ridley Scott and starring Harrison Ford, Continue reading →

Posted in - Opinion, - Reviews, books, devices, Genetics, Geriatrics, Obstetrics and Gynecology, Oncology, Ophthalmology | Leave a comment

Maybe my brain was spared

Posted on January 4, 2018 by admin

July 26, 2017- by Steven E. Greer, MD

Last week, I sat next to an Ohio State University offensive lineman while attending a Roger Waters Continue reading →

Posted in - JAMA, - Reviews, books, devices, Neurology, Neurosurgery, Ohio State | Leave a comment

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

Posted on January 3, 2018 by admin

January 12, 2017- Interviewed by Steven E. Greer, MD

Jonathan Strosberg, MD of Continue reading →

Posted in - NEJM, Oncology | Leave a comment

Told you so: The White House Press Office Is In Chaos

Posted on January 2, 2018 by admin

August 16, 2017- The White Announced that Hope Hicks will be the interim communications director. Continue reading →

Posted in - Opinion, - Policy, Congress | Leave a comment

A modern medical wonder finishes second in the U.S. Open golf tournament

Posted on January 2, 2018 by admin

Erik-Compton-at-US-OpenJune 15, 2014- By Steven E. Greer, MD

34-year-old Erik Compton finished tied for second in the United States Open golf tournament. Continue reading →

Posted in - Opinion, Cardiology, Transplant surgery | Leave a comment

Vagal nerve stimulation for weight loss

Posted on January 2, 2018 by admin

January 22, 2015- Interviewed by Steven E. Greer, MD

Erik Dutson, MD, bariatric surgeon from UCLA, discusses the newly FDA-approved weight loss device called Continue reading →

Posted in - Medical Devices, Bariatric surgery, Diabetes and endocrinology, Gastroenterology and liver, Primary care medicine, UCLA | Leave a comment

Review of combination immunotherapies seen at ASCO 2016

Posted on January 2, 2018 by admin

June 22, 2016- interviewed by Steven E. Greer, MD

We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, Continue reading →

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment